Serina Therapeutics SER
NYSE SER
$2.43 -0.14 (-5.36%)
As of: Sep 10, 2026 · 3:59 PM EDT

Serina Therapeutics (SER) Treasury Shares (2022 - 2023)

Serina Therapeutics' (SER) quarterly Treasury Shares came in at $3.4 million in Q4 2023, up 3.46% year-over-year from $3.3 million in Q4 2022, and little changed quarter-over-quarter from $3.4 million in Q3 2023.

Analysis

Serina Therapeutics (SER) Treasury Shares (2022 - 2023) Analysis & Trends

Serina Therapeutics has disclosed Treasury Shares across 2 years of filings, most recently posting $3.4 million for Q4 2023.

  • In Q4 2023, Treasury Shares rose 3.46% year-over-year to $3.4 million; the TTM figure through Dec 2023 stood at $3.4 million (up 3.46% YoY), while the FY2023 annual figure was $3.4 million, up 3.46% from the prior year.
  • Treasury Shares came in at $3.4 million for Q4 2023 at Serina Therapeutics, roughly flat from $3.4 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.4 million in Q3 2023 to a low of $3.3 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Serina Therapeutics 40.47 Mn 17.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 3.44 Mn
Dec 31, 2023 3.44 Mn
Sep 30, 2023 3.44 Mn
Sep 30, 2023 3.44 Mn
Jun 30, 2023 3.32 Mn
Jun 30, 2023 3.32 Mn
Mar 31, 2023 3.32 Mn
Mar 31, 2023 3.32 Mn
Dec 31, 2022 3.32 Mn
Dec 31, 2022 3.32 Mn